Next Article in Journal
Dendrobium nobile Lindley Administration Attenuates Atopic Dermatitis-like Lesions by Modulating Immune Cells
Next Article in Special Issue
PCV2 and PRV Coinfection Induces Endoplasmic Reticulum Stress via PERK-eIF2α-ATF4-CHOP and IRE1-XBP1-EDEM Pathways
Previous Article in Journal
The Discovery of Potent SHP2 Inhibitors with Anti-Proliferative Activity in Breast Cancer Cell Lines
Previous Article in Special Issue
Establishment of Human-Induced Pluripotent Stem Cell-Derived Neurons—A Promising In Vitro Model for a Molecular Study of Rabies Virus and Host Interaction
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 23
Issue 8
10.3390/ijms23084469
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Coinfection of Porcine Circovirus 2 and Pseudorabies Virus Enhances Immunosuppression and Inflammation through NF-κB, JAK/STAT, MAPK, and NLRP3 Pathways

by
Xue Li
†,
Si Chen
†,
Liying Zhang
†,
Guyu Niu
,
Xinwei Zhang
,
Lin Yang
,
Weilong Ji
and
Linzhu Ren
*
College of Animal Sciences, Key Lab for Zoonoses Research, Ministry of Education, Jilin University, 5333 Xi’an Road, Changchun 130062, China
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Int. J. Mol. Sci. 2022, 23(8), 4469; https://doi.org/10.3390/ijms23084469
Submission received: 29 March 2022 / Revised: 16 April 2022 / Accepted: 17 April 2022 / Published: 18 April 2022
(This article belongs to the Special Issue The Interaction between Cell and Virus)
Browse Figures
Versions Notes

Abstract

:
Porcine circovirus 2 (PCV2) and pseudorabies virus (PRV) are economically important pathogens in swine. PCV2 and PRV coinfection can cause more severe neurological and respiratory symptoms and higher mortality of piglets. However, the exact mechanism involved in the coinfection of PRV and PCV2 and its pathogenesis remain unknown. Here, porcine kidney cells (PK-15) were infected with PCV2 and/or PRV, and then the activation of immune and inflammatory pathways was evaluated to clarify the influence of the coinfection on immune and inflammatory responses. We found that the coinfection of PCV2 and PRV can promote the activation of nuclear factor-κB (NF-κB), c-Jun N-terminal protein kinases (JNK), p38, and nod-like receptor protein 3 (NLRP3) pathways, thus enhancing the expression of interferon-γ (IFN-γ), interferon-λ1 (IFN-λ1), interferon-stimulated gene (ISG15), interleukin 6 (IL6), and interleukin 1β (IL1β). Meanwhile, PCV2 and PRV also inhibit the expression and signal transduction of IFN-β, tumor necrosis factor α (TNFα), and the Janus kinase-signal transducer and activator of transcription (JAK/STAT) pathway. In addition, PCV2 and PRV infection can also weaken extracellular-signal-regulated kinase (ERK) activity. These results indicate that the regulations of cellular antiviral immune responses and inflammatory responses mediated by NF-κB, JAK/STAT, mitogen-activated protein kinase (MAPK), and NLRP3 pathways, contribute to immune escape of PCV2 and PRV and host antiviral responses.

1. Introduction

Porcine circovirus 2 (PCV2) is the causative agent of porcine circovirus diseases and porcine circovirus-associated diseases (PCVD/PCVAD), which are distributed worldwide, and the positive rate of pigs infected with PCV2 is high, or even more than 90% [1,2]. However, more and more evidence shows that a single infection with PCV2 will not lead to obvious cytopathic effect (CPE) in vitro and clinical disease in vivo [2,3,4], and most single infection cases of PCV2 result in subclinical symptoms with significant immunosuppression in pigs [2,5]. Subsequently, the immunosuppression induced by PCV2 infection is beneficial to the secondary infection of other pathogens. Therefore, coinfections of PCV2 with other pathogens, including viruses and bacteria, etc., become the main factors causing severe diseases in pigs [2,4].
Among pathogens co-infected with PCV2, viruses are the most common causes of severe diseases. As reported, the coinfection rates of PCV2 with porcine reproductive and respiratory syndrome virus (PRRSV), pseudorabies virus (PRV), classical swine fever virus (CSFV), and porcine epidemic diarrhea virus (PEDV) were 26.73%, 18.37%, 13.06%, and 3.47%, respectively, in Shandong province in China from 2015 to 2018 [6]. It is worth noting that coinfection of PCV2 with type 1 modified live vaccine-like PRRSV strain (MLV1-like) resulted in increased virulence in the infected pigs [7]. Sequential infection of piglets with highly pathogenic PRRSV and PCV2 exhibited synergistic effects and more severe clinical symptoms and lesions on piglets [8]. However, so far, only a few studies have focused on the pathogenesis of PCV2 and PRV coinfection.
PRV (also named Suid herpesvirus 1) belongs to the genus Varicellovirus, Alphaherpesvirinae subfamily, the family Herpesviridae, which mainly causes neurological symptoms and high mortality of piglets, growth retardation, and respiratory disorders in growing pigs, and reproductive failure of sows [9]. Although PRV infection has been successfully controlled in several countries, PRV is still one of the most important pathogens of swine and wild boar all over the world, especially the highly pathogenic PRV that has emerged in recent years, due to the recombination between wild PRV and the attenuated live vaccine strain [1,3,10,11].
It was reported that PCV2 can promote the expression of interleukin 6 (IL6), IL8, IL10, pro-inflammatory cytokines, and activate nuclear factor-κB (NF-κB), thus coordinating cellular immune response and inflammatory reaction, and promoting virus infection [12,13,14]. PCV2 inhibits interferon-β (IFN-β) through the p38-mitogen-activated protein kinase (MAPK) pathway [15] but also enhances IFN-β via retinoic acid-inducible gene I (RIG-1) and interferon regulatory factor 7 (IRF7) signaling pathways [16]. Moreover, PCV2 infection can induce immunosuppression in pigs, but external immuno-stimulation, such as vaccination and coinfection, has been proved to aggravate PCVAD [13]. Furthermore, PRV infection triggers persistent and aberrant NF-κB activation through DNA damage response but inhibits NF-κB-dependent gene expression [17,18]. PRV also activates cytokine storms by upregulating the expression levels of IFN-α, IFN-β, tumor necrosis factor α (TNFα), IL1β, IL6, and IL18, and stimulates the pyroptosis pathway, by enhancing the expression levels of nod-like receptor protein 3 (also named NACHT, LRR, and PYD domains-containing protein 3, NLRP3), caspase-1, Gasdermin-D, and IL1β/18 [19]. Virulent PRV induces specific and fatal systemic inflammation through two main cytokines IL6 and granulocyte colony-stimulating factor (G-CSF) [20]. Notably, coinfection of PCV2 and PRV caused more severe neurological and respiratory symptoms and higher mortality of piglets, with an increased PRV replication in brain and lung tissues [3]. PCV2 and PRV coinfection is also considered the main cause of porcine respiratory disease complex (PRDC) [2]. PCV2 infection can lead to interleukin 10 (IL-10)- mediated immunosuppression [21,22], which may impair immune responses against PRV, resulting in more severe disease or vaccination failure against PRV [21,22,23,24]. However, the exact mechanism involved in the coinfection of PRV and PCV2, and its pathogenesis, remain unknown. Therefore, it is necessary to analyze the regulatory mechanism of PCV2 and PRV coinfection on immune response and inflammatory reaction, so as to provide a theoretical basis, and effective targets, for the prevention and control of related diseases. In the present study, porcine kidney cells (PK-15) were infected individually or co-infected with PCV2 and/or PRV, followed by an evaluation of the immune and inflammatory pathways involved.

2. Results

2.1. Coinfection of PCV2 and PRV Inhibit Each Other

To evaluate the replication of PCV2 and PRV, PK-15 cells were infected with different combinations of PCV2 and PRV, including PCV2 or PRV single infection, PCV2 and PRV coinfections (PCV2+PRV group, PCV2-12h-PRV group, and PRV-12h-PCV2 group). As shown in Figure 1, all PCV2 and/or PRV infected groups can replicate in PK-15 cells, suggesting that coinfection of PCV2 and PRV is feasible in vitro. Furthermore, the growth curves of PCV2 and PRV in the coinfection groups were similar. Compared with the single infection, the copy number of PCV2 in the coinfection group decreased at 24 to 48 hpi, suggesting that PRV may inhibit the proliferation of PCV2 (Figure 1A). Compared with PRV infection alone, the coinfection group PCV2-12h-PRV can inhibit PRV proliferation (Figure 1B). The growth curves of PRV in the coinfection groups (PCV2+PRV group, PRV-12h-PCV2 group) were similar to that of the PRV single infection group.

2.2. Coinfection of PCV2 and PRV Inhibits the Expression of IFN-β, IRF3, and ISG56/IFIT1 but Promotes the Expression of IFN-γ, IFN-λ1, IRF7, and ISG15

IFNs are important components of the innate immune response against virus infection. Therefore, the expression levels of IFNs were detected by Western blot. As shown in Figure 2, the levels of IFN-α in the infected groups had no significant difference compared with the control group. On the contrary, levels of IFN-β showed a decrease in the infected groups, especially in the co-infected groups (Figure 2). Levels of IFN-γ were decreased in cells infected with PCV2 or PRV alone but increased in the coinfection groups (Figure 2). Notably, levels of IFN-λ1 were enhanced in all the infected groups compared with the control group (Figure 2).
IRFs, especially IRF3 and IRF7, are members of the interferon regulatory factor family, which are closely related to the expression of interferon genes during virus infection [25,26]. Compared with the control group, the expression of the IRF3 gene in all groups with PCV2 was inhibited, whereas PRV infection alone does not affect IRF3 expression (Figure 3A), indicating PCV2 may be the dominant factor for IRF3 inhibition, thus inhibiting IRF3-related immune response.
Compared with the control group, expression levels of the IRF7 gene were enhanced in all groups containing PRV, including single- and co-infected groups, but there was no difference in the PCV2 single-infected group (Figure 3B). These results suggest that coinfection of PCV2 and PRV induces immune responses by activating IRF7. To further confirm these results, Western blotting was performed to examine the protein levels of IRF7. As shown in Figure 3C, levels of IRF7 were enhanced in the virus-infected groups compared to that of the control group, which is more obvious in PRV-containing groups. Therefore, the down-regulation of IRF3 expression is mainly caused by PCV2 infection, whereas PRV mainly modulates the expression of IRF7. The coinfection of the two viruses can obviously up-regulate IRF7 in cells.
Moreover, expression levels of IFN-stimulated gene 15 (ISG15) were increased in cells infected with PCV2 alone compared with that of the control group (Figure 3D), whereas no obvious difference in ISG56/IFIT1 gene was observed in the cells infected with PCV2 alone (Figure 3E). The expression level of the ISG56 gene was significantly decreased in cells infected with PRV alone than in the control group (Figure 3E), whereas no obvious difference in the ISG15 gene was observed in the cells infected with PRV alone (Figure 3D). Expression levels of the ISG15 gene in the co-infected groups were up-regulated compared with the PRV group, while expression levels of the ISG56 gene in the co-infected groups were down-regulated compared with the PCV2 group (Figure 3D,E).
These results indicate that coinfection of PCV2 and PRV inhibited the expression of IRF3, IFN-β, and ISG56, but promoted the expression of IRF7, IFN-γ, IFN-λ1, and ISG15.

2.3. Coinfection of PCV2 and PRV Suppress JAK1- and STAT1-Related JAK/STAT Pathways

The Janus kinase-signal transducer and activator of transcription (JAK/STAT) pathway is one of the important signal pathways downstream of cytokine receptors [27]. IFN activates the JAK/STAT pathway, which then amplifies the IFN signal and modulates the expression of antiviral factors [27]. As shown in Figure 4, expression levels of the JAK1 gene were significantly inhibited in all the virus-infected groups, including single and co-infected groups compared to that of the control group (Figure 4A), whereas expression levels of the suppressors of cytokine signaling 1 gene (SOCS1) (Figure 4B), a negative regulator of the JAK/STAT signaling pathway, was significantly increased in the virus-infected groups. PCV2 infection alone does not affect the expression of the SOCS3 gene, while PRV infection alone and coinfection of PCV2 and PRV significantly promoted the expression of the SOCS3 gene (Figure 4C). Furthermore, although the expression of the STAT1 gene was up-regulated in the PCV2 alone group, it was down-regulated significantly in other infected groups (Figure 4D). Moreover, the phosphorylation levels of STAT1 (p-STAT1/STAT1) were inhibited in all the coinfection groups (Figure 4E,F). In addition, compared with the control group, expression levels of the IRF9 gene were enhanced in all groups infected with PRV, including single- and co-infected groups (Figure 4G). Furthermore, the expression levels of the IRF9 gene in coinfection groups were significantly lower than those in the PRV single-infected group (Figure 4G). These results further confirmed the results in Figure 4E, that the expressions of IRF9 were enhanced in the virus-infected groups compared to that of the control group (Figure 4E).
Thus, coinfection of PCV2 and PRV can prevent the cascade of IFN signals by inhibiting the JAK1 and STAT1 (Figure 4). Coinfection of PCV2 and PRV leads to stronger immunosuppression on the IFN-JAK/STAT pathway than virus infection alone (Figure 2, Figure 3 and Figure 4).

2.4. Coinfection of PCV2 and PRV Modulates NF-κB Signal Pathway

Nuclear factor-κB (NF-κB) plays a crucial role in regulating host immune responses and inflammation [28]. Therefore, levels of two NF-κB related factors, p65 and iκB, in PCV2 and/or PRV-infected cells were evaluated at 36 hpi via real-time PCR and western blotting. As shown in Figure 5A, compared with the control group, PRV infection alone and coinfection with PCV2 significantly inhibited the expression of the p65 gene, while PCV2 infection alone had no significant effect on the expression of the p65 gene. Furthermore, PCV2 infection alone and coinfection significantly promoted the expression of the iκB gene (Figure 5B). These results suggest that the single infection or coinfection of PRV and PCV2 may partially inhibit NF-κB at transcription levels.
Compared with the control group, total proteins of p65 and iκB showed a slight or significant decrease in almost all the infected groups. However, levels of phosphorylated p65 (p-p65) and iκB (p-iκB) were significantly increased in the coinfected groups (Figure 5C–E). These results indicate that infection of PCV2 and PRV alone, or in combination, can stimulate the NF-κB signaling pathway at the translational level, and the cells infected with PRV exhibit more obvious stimulation of NF-κB signals.

2.5. Coinfection of PCV2 and PRV Modulates Expressions of Host Pro-Inflammatory Factors

Inflammation is a critical part of the host immune system’s response to infection. To assess the effect of viral infection on cellular inflammation, the expressions of several inflammatory factors were detected by real-time PCR. The results showed that PCV2 infection alone enhanced the expression levels of the IL1α gene (Figure 6A) and TNFα gene (Figure 6B), whereas PRV infection alone increased the expression of the IL6 gene (Figure 6C).
Compared with the PCV2 infection alone, coinfection of PCV2 and PRV decreased the expression levels of the IL1α gene (Figure 6A) and TNFα gene (Figure 6B) but increased the expression level of the IL6 gene (Figure 6C) and IL1β gene (Figure 6D). Compared with the PRV infection alone, coinfection of PCV2 and PRV increased the expression levels of the IL1α gene (Figure 6A) and IL1β gene (Figure 6D), but decreased the expression level of the IL6 gene (Figure 6C). The protein levels of IL6, and IL1β detected by Western blotting further confirmed these results (Figure 6E). However, the protein levels of TNFα in all infected groups were inhibited, and the inhibitions of TNFα in the coinfection groups were slightly stronger (Figure 6E), suggesting the virus may inhibit the expression of TNFα and then inhibit the aggravation of cellular inflammatory reaction. The above results further indicate that coinfection of PCV2 and PRV modulate expressions of host pro-inflammatory factors. The coinfection of PCV2 and PRV weakened the regulatory effect of a single virus infection on inflammation.
Inflammasomes regulate the activity of caspase-1 and the maturation of IL1β and IL-18, which act as innate immune system sensors and receptors in various infections, cancer, and other diseases, among which the NLRP3 inflammasome has been well characterized to date [29,30,31]. Therefore, the activity of the NLRP3 inflammasome in PRV and/or PCV2 infected cells was evaluated. As shown in Figure 7, the expression levels of the NLRP3 gene (Figure 7A) and cyclooxygenase 2 (COX2/PTGS2) gene (Figure 7B) were enhanced in all PRV- infected cells compared with that of the control group. Furthermore, the enhancement effects of NLRP3 and COX2 were significantly higher in the PRV single-infection group and two sequential infection groups than those in the coinfection group (PCV2+PRV). These results were further confirmed by Western blotting that the levels of NLRP3 and COX2 increased in all infected cells, especially NLRP3 (Figure 7C). Therefore, infection of PCV2 and PRV caused NLRP3-mediated cellular inflammatory reaction, and the coinfection of PCV2 and PRV aggravated the inflammation.

2.6. Coinfection of PCV2 and PRV Activates Inflammatory and Immune via p38 and JNK1/2

The MAPK pathways are important signal pathways involved in various cellular processes, including inflammatory reactions and immunity, etc. [32]. Therefore, levels of MAPKs, including c-Jun N-terminal protein kinases 1/2 (JNK1/2), p38, and extracellular-signal-regulated kinases 1/2 (ERK1/2), in cells infected with PCV2 and PRV alone or in combination were examined. The results showed that expression levels of the p38α gene and ERK2 gene significantly decreased in all the virus-infected groups, including single- and co-infected groups, compared to that of the control group (Figure 8A,B). The expression levels of the JNK1 gene were decreased in single- and co-infected groups compared with that of the control group (Figure 8C). On the contrary, both phosphorylated p38 (p-p38) and JNK1/2 (p-JNK1/2) were enhanced in all the infected groups (Figure 8D–F), whereas phosphorylated ERK1/2 (p-ERK1/2) were inhibited in all the infected groups, except the PCV2 alone group (Figure 8D,G).
The above results indicate that single infection and coinfection of PCV2 and PRV can induce inflammation and immune responses by activating p38 and JNK1/2.

3. Materials and Methods

3.1. Cells and Virus

The porcine kidney cell line (PK-15, ATCC CCL-33) was previously purchased from American Tissue Culture Collection (ATCC, Manassas, VA, USA) and used in our lab [33,34]. PCV2 CC1 (GenBank accession: JQ955679) and PRV (Submission ID: 2573364) were isolated previously and stored in our lab [33,34].
PK-15 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Gibco, Therm Fisher Scientific, Shanghai, China) containing 5% fetal bovine serum (FBS, Clark Bioscience, Shanghai, China) at 37 °C, 5% CO2.

3.2. Viral Infection

Cells were plated in a 6-well plate for 12 h to reach 50–60% confluency and divided into 6 groups for virus infection. Group 1 was used as a control group (PK-15 group). Group 2 was infected with PCV2 alone (PCV2 group), and group 3 was infected with PRV alone (PRV group). Cells were infected with PCV2 (5 × 104 genomic copies/μL, 600 μL/well) or PRV (103 genomic copies/μL, 600 μL/well) alone for 1 h. Then, cells were washed with PBS twice and cultured in 2 mL fresh DMEM (5% FBS). After that, 36 h later, samples were collected and evaluated via real-time PCR or Western blotting.
Group 4 to group 6 were co-infected groups. In group 4 (PCV2-12h-PRV group), cells were infected with PCV2 (5 × 104 genomic copies/μL, 600 μL/well) for 1 h, washed with PBS twice and cultured in 2 mL fresh DMEM (5% FBS). Then, 12 h later, cells were incubated with PRV (103 genomic copies/μL, 600 μL/well) for 1 h and washed with PBS twice and cultured in 2 mL fresh DMEM (5% FBS) for 36 h. In group 5 (PRV-12h-PCV2 group), cells were infected with PRV (103 genomic copies/μL, 600 μL/well) for 1 h, washed with PBS twice and cultured in 2 mL fresh DMEM (5% FBS). Once 12 h had elapsed, cells were incubated with PCV2 (5 × 104 genomic copies/μL, 600 μL/well) for 1 h and washed with PBS twice and cultured in 2 mL fresh DMEM (5% FBS) for 36 h. Then, samples were collected and evaluated via real-time PCR or Western blotting. In group 6 (PCV2+PRV group), cells were co-infected with PCV2 (105 genomic copies/μL, 300 μL/well) and PRV (2 × 103 genomic copies/μL, 300 μL/well) for 1 h. Then, cells were washed with PBS twice and cultured in 2 mL fresh DMEM (5% FBS). After that, 36 h later, samples were collected and evaluated via real-time PCR or Western blotting.

3.3. Real-Time PCR

Virus genomic DNA was extracted using TIANamp Virus DNA/RNA Kit (Tiangen, Beijing, China) according to the manufacturer’s instructions. Then, real-time PCR was performed using primers PCV2-Q-F/R or PRV-Q-F/R (Table S1) to evaluate levels of virus genomic DNA [35,36].
Total RNA was extracted from mock and the virus-infected cells at 36 hpi using TRNzol Universal Reagent (Tiangen, Beijing, China), and reverse-transcribed in cDNA using FastKing gDNA Dispelling RT SuperMix (Tiangen, Beijing, China), according to the manufacturer’s instructions. Thereafter, expression levels of host genes were evaluated via real-time PCR with corresponding primer pairs (Table S1). Quantitative real-time PCR (qRT-PCR) and relative mRNA levels were performed using the 2−ΔΔCt method, and mRNA levels were calibrated and compared with the cells that had undergone 36 h in PK-15.

3.4. Western Blotting

Total protein was extracted from mock and the virus-infected cells at 36 hpi. Briefly, cells were washed with PBS twice, digested with trypsin, and centrifuged at 1000 rpm for 5 min. The collected cells were lysed with 200 μL cell lysis buffer for Western and IP (Beyotime, Shanghai, China) on ice for 30 min, followed by centrifugation at 12,000 rpm, 4 °C for 20 min. The supernatant was transferred into a clean tube and quantified using an Enhanced BCA Protein Assay Kit (Beyotime, Shanghai, China), according to the manufacturer’s instructions.
Western blotting was performed according to the protocol described by Ouyang previously [37]. Briefly, protein samples were separated via 10% SDS-PAGE and electro-transformed onto the PVDF membrane. Then, the membrane was blocked with 5% skim milk for 2 h at room temperature and incubated with primary antibody at 4 °C overnight. Thereafter, the membrane was incubated with HRP-labeled Goat Anti-mouse IgG (H+L), HRP-labeled Donkey Anti-Goat IgG(H+L), or HRP-labeled Goat Anti-rabbit IgG (H+L) (1/2000, Beyotime, China) for 90 min at room temperature. Subsequently, the protein band was developed using an ECL kit (WLA006a, WanleiBio, Shenyang, China) and examined via Bioanalytical Imaging System c600 (Azure Biosystems, Dublin, CA, USA).
Interferon beta/IFNB, IFN-γ, P-IΚBα (Ser32 Ser36), IΚB-α, IL1α, IL6, TNFα, NLRP3, Cox-2, P38, and p-p38 (Thr180/Tyr182) were purchased from Wanleibio (rabbit, Shenyang, China). Anti-STAT1 Antibody (rabbit) and Anti-β-Actin Antibody (mouse) were purchased from Boster Biological Technology (Wuhan, China). NFκB p65 Polyclonal Antibody and Phospho-NFκB p65 (Thr276) Polyclonal Antibody were from Therm Fisher Scientific (rabbit, Shanghai, China). IL28/29 (H-1) (mouse), JNK (FL) (rabbit), and p-JNK (Thr 183/Tyr 185, goat) were purchased from Santa Cruz Biotechnology (Dallas, TX, USA). Interferon-alpha 1 Ab, p-STAT1, and IRF9 Antibody were purchased from Affinity Biosciences (rabbit, Changzhou, China). ERK p44/42 MAPK (Erk1/2) (137F5) Rabbit mAb and Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (D13.14.4E) XP® Rabbit mAb were from Cell Signaling Technology (Boston, MA, USA). IL1B Antibody was from Cusabio Biotech (rabbit, Wuhan, China). Rabbit Anti-IRF7 antibody was from Bioss (rabbit, Beijing, China).
Grayscale values were calculated and analyzed with Image-Pro Plus 6.0.0.260 (Media Cybernetics, Rockville, MD, USA). Grayscale values were recorded three times. The relative expression of each protein was expressed as mean grayscale values of target protein/mean grayscale values of β-actin. The average value of the relative expression is shown below each lane.

3.5. Statistical Analysis

All data are shown as representative results or means from at least three independent experiments ± SD. The statistical analysis was conducted using GraphPad Prism 8.0.2 (San Diego, CA, USA) with a One-way or Two-way analysis of variance (ANOVA). The resulting p < 0.05 was a statistically significant difference.

4. Discussion

Coinfection of viruses and/or bacteria has been frequently reported in the field [1,2,4,6,10,38,39,40]. Recent reports showed that coinfection of PCV2 and PRV is relatively high in the field [1,6,10], which may aggravate the diseases and reduce the vaccine protection rate, thus causing the virus to become widespread. Previous studies have shown that PCV2 can inhibit the production of IFN-α and IFN-β [15,41], and herpesvirus can escape the cellular immune responses induced by IFNs and the JAK/STAT pathway [42,43,44]. In this study, the changes in immune-related signal pathways and inflammatory factors caused by PCV2 and PRV infection alone or in combination were evaluated. The results indicate that the expressions of IFN-γ, IFN-λ1, IRF7, and ISG15 were enhanced during the coinfection of PCV2 and PRV. However, coinfection of PCV2 and PRV can prevent the cascade of IFN signals by inhibiting the JAK/STAT pathway (Figure 4), suggesting coinfection of PCV2 and PRV has stronger immunosuppression on the IFN-JAK/STAT pathway than that of the PCV2 and PRV infection alone (Figure 2, Figure 3 and Figure 4). Based on this, the suggestion is that viral infection enhances the initiation of the immune state of the host cell, but evades the immune response by inhibiting the IFN-JAK/STAT pathway. Notably, coinfection of PCV2 and PRV also promotes the expression of IFN-λ1, which is consistent with previous reports that type III IFN can be used to inhibit influenza and coronavirus infections [45,46], suggesting that type III IFN is a promising antiviral agent against PCV2 and/or PRV infections.
Furthermore, the results in this study also demonstrated that infection of PCV2 and PRV alone or in combination can stimulate the NF-κB signaling pathway by enhancing the levels of phosphorylated p65 and iκB (Figure 5). Both phosphorylated p38 and JNK1/2 were enhanced in all the infected groups (Figure 8). These results indicate that NF-κB and MAPK pathways mediate antiviral immune responses and the activation of inflammatory factors in PCV2 and PRV coinfection, which is consistent with previous results of PCV2 or PRV infections alone [15,18,47,48,49]. These results also confirm our above results, that is, the up-regulation of IFN-λ1, ISG15, IRF9, IL6, and IL1β may be related to NF-κB and MAPK pathways.
TNFα is an important pleiotropic cytokine, which is involved in host immunity, inflammation, and apoptosis [19,50,51]. TNFα can be used as a pro-inflammatory factor to stimulate strong inflammatory reactions and immunosuppression and maintain immune homeostasis by limiting the degree and duration of the inflammatory process [50,51]. We found in this study that PCV2 infection alone enhanced the expression levels of the TNFα gene more than that of the control group (Figure 6). Compared with PCV2 infection alone, coinfection of PCV2 and PRV decreased the expression levels of the TNFα gene. However, the protein levels of TNFα in all infected groups were inhibited, and the inhibitions of TNFα in the coinfection groups were slightly stronger compared with single infections. These results indicate that the virus may inhibit the aggravation of cellular inflammation by inhibiting the expression of TNFα. However, compared with PCV2 infection alone, coinfection of PCV2 and PRV decreased the levels of the IL1α gene but increased the level of the IL6 gene and IL1β gene. Compared with PRV infection alone, coinfection of PCV2 and PRV increased the levels of the IL1α gene and IL1β gene but decreased the level of the IL6 gene. Furthermore, infection of PCV2 and PRV caused inflammasome proteins NLRP3 and COX2-mediated cellular inflammatory reaction, and the coinfection of PCV2 and PRV aggravated the inflammation (Figure 7). These results demonstrate that coinfection of PCV2 and PRV may cause more severe inflammatory reactions and immune disorders.
Therefore, the coinfection of PCV2 and PRV shows a stronger ability to induce inflammation and immunosuppression through several cellular pathways, which may be one of the reasons for the aggravation of infected animals. The coinfection of PCV2 and PRV can promote the activation of NF-κB, JNK, p38, and NLRP3 pathways, thus enhancing the expression of IL6 and IL1β, and finally potentiating cellular inflammation. Meanwhile, PCV2 and PRV also inhibit the expression and signal transduction of the IFN-β, TNFα, and JAK/STAT pathways, thus inhibiting inflammation and immune responses (Figure 9). It is worth mentioning that the changes in the expression levels of the inflammatory factors and cytokines also imply that there is a regulatory mechanism to maintain dynamic balance in the interaction between host cells and viruses, which not only has antiviral inflammation and immune responses but also has a protective mechanism to inhibit excessive inflammatory damage. Further research on the exact mechanism of PCV2 and PRV coinfection on host cell inflammation and the immune response is in progress in our lab.

5. Conclusions

In conclusion, the results of this study showed that the coinfection of PCV2 and PRV can promote the activation of NF-κB, JNK, p38, and NLRP3 pathways, thus enhancing the expression of IL6 and IL1β, and finally potentiating cellular inflammation. Meanwhile, PCV2 and PRV also inhibit the expression and signal transduction of the IFN-β, TNFα, and JAK/STAT pathways, thus inhibiting immune responses. These results indicate that the regulations of cellular antiviral immune responses and inflammatory responses mediated by NF-κB, JAK/STAT, MAPK, and NLRP3 pathways, contribute to immune escape of PCV2 and PRV and host antiviral responses, which may be of great value for the research and control of infection and related diseases of PCV2 and PRV.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijms23084469/s1. References [35,36] are cited in the supplementary materials.

Author Contributions

Data curation, X.L. and S.C.; Formal analysis, L.Z. and X.Z.; Funding acquisition, L.R.; Methodology, X.L. and S.C.; Project administration, L.R. and L.Z.; Supervision, L.R.; Validation, G.N. and L.Y.; Writing—original draft, X.L. and S.C.; Figures, W.J. and X.L.; Writing—review & editing, L.R. and L.Z. All authors have read and agreed to the published version of the manuscript.

Funding

This work was financially supported by the Changchun Science and Technology Bureau project [Grant No: 21ZGN18]; the Jilin Province Science and Technology Development Projects [Grant No.: 20200402043NC], the National Natural Science Foundation of China [Grant No.: 31772747]. The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All data generated or analyzed during this study are included in this published article.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Ma, Z.; Han, Z.; Liu, Z.; Meng, F.; Wang, H.; Cao, L.; Li, Y.; Jiao, Q.; Liu, S.; Liu, M. Epidemiological investigation of porcine pseudorabies virus and its coinfection rate in Shandong Province in China from 2015 to 2018. J. Vet. Sci. 2020, 21, e36. [Google Scholar] [CrossRef]
  2. Ouyang, T.; Zhang, X.; Liu, X.; Ren, L. Co-Infection of Swine with Porcine Circovirus Type 2 and Other Swine Viruses. Viruses 2019, 11, 185. [Google Scholar] [CrossRef] [Green Version]
  3. Zhang, X.; Shu, X.; Bai, H.; Li, W.; Li, X.; Wu, C.; Gao, Y.; Wang, Y.; Yang, K.; Song, C. Effect of porcine circovirus type 2 on the severity of lung and brain damage in piglets infected with porcine pseudorabies virus. Vet. Microbiol. 2019, 237, 108394. [Google Scholar] [CrossRef]
  4. Saade, G.; Deblanc, C.; Bougon, J.; Marois-Crehan, C.; Fablet, C.; Auray, G.; Belloc, C.; Leblanc-Maridor, M.; Gagnon, C.A.; Zhu, J.; et al. Coinfections and their molecular consequences in the porcine respiratory tract. Vet. Res. 2020, 51, 80. [Google Scholar] [CrossRef]
  5. Kim, D.; Ha, Y.; Oh, Y.; Chae, C. Prevalence of porcine circovirus types 2a and b in pigs with and without post-weaning multi-systemic wasting syndrome. Vet. J. 2011, 188, 115–117. [Google Scholar] [CrossRef]
  6. Ma, Z.; Liu, M.; Liu, Z.; Meng, F.; Wang, H.; Cao, L.; Li, Y.; Jiao, Q.; Han, Z.; Liu, S. Epidemiological investigation of porcine circovirus type 2 and its coinfection rate in Shandong province in China from 2015 to 2018. BMC Vet. Res. 2021, 17, 17. [Google Scholar] [CrossRef]
  7. Eclercy, J.; Larcher, T.; Andraud, M.; Renson, P.; Bernard, C.; Bigault, L.; Ledevin, M.; Paboeuf, F.; Grasland, B.; Rose, N.; et al. PCV2 co-infection does not impact PRRSV MLV1 safety but enhances virulence of a PRRSV MLV1-like strain in infected SPF pigs. Vet. Microbiol. 2020, 244, 108656. [Google Scholar] [CrossRef]
  8. Fan, P.; Wei, Y.; Guo, L.; Wu, H.; Huang, L.; Liu, J.; Liu, C. Synergistic effects of sequential infection with highly pathogenic porcine reproductive and respiratory syndrome virus and porcine circovirus type 2. Virol. J. 2013, 10, 265. [Google Scholar] [CrossRef] [Green Version]
  9. Li, W.; Zhuang, D.; Li, H.; Zhao, M.; Zhu, E.; Xie, B.; Chen, J.; Zhao, M. Recombinant pseudorabies virus with gI/gE deletion generated by overlapping polymerase chain reaction and homologous recombination technology induces protection against the PRV variant PRV-GD2013. BMC Vet. Res. 2021, 17, 164. [Google Scholar] [CrossRef]
  10. Zhou, H.; Pan, Y.; Liu, M.; Han, Z. Prevalence of Porcine Pseudorabies Virus and Its Coinfection Rate in Heilongjiang Province in China from 2013 to 2018. Viral Immunol. 2020, 33, 550–554. [Google Scholar] [CrossRef]
  11. He, W.; Auclert, L.Z.; Zhai, X.; Wong, G.; Zhang, C.; Zhu, H.; Xing, G.; Wang, S.; He, W.; Li, K.; et al. Interspecies Transmission, Genetic Diversity, and Evolutionary Dynamics of Pseudorabies Virus. J. Infect Dis. 2019, 219, 1705–1715. [Google Scholar] [CrossRef] [PubMed]
  12. Choi, C.Y.; Rho, S.B.; Kim, H.S.; Han, J.; Bae, J.; Lee, S.J.; Jung, W.W.; Chun, T. The ORF3 protein of porcine circovirus type 2 promotes secretion of IL-6 and IL-8 in porcine epithelial cells by facilitating proteasomal degradation of regulator of G protein signalling 16 through physical interaction. J. Gen. Virol. 2015, 96 Pt 5, 1098–1108. [Google Scholar] [CrossRef]
  13. Meng, X.J. Porcine circovirus type 2 (PCV2): Pathogenesis and interaction with the immune system. Annu. Rev. Anim. Biosci. 2013, 1, 43–64. [Google Scholar] [CrossRef]
  14. Li, C.; Sun, Y.; Jiang, C.; Cao, H.; Zeng, W.; Zhang, X.; Li, Z.; He, Q. Porcine circovirus type 2 infection activates NF-kappaB pathway and cellular inflammatory responses through circPDCD4/miR-21/PDCD4 axis in porcine kidney 15 cell. Virus Res. 2021, 298, 198385. [Google Scholar] [CrossRef] [PubMed]
  15. Wu, X.; Wang, Z.; Qiao, D.; Yuan, Y.; Han, C.; Yang, N.; Li, R.; Du, Q.; Tong, D.; Huang, Y. Porcine circovirus type 2 infection attenuates the K63-linked ubiquitination of STING to inhibit IFN-beta induction via p38-MAPK pathway. Vet. Microbiol. 2021, 258, 109098. [Google Scholar] [CrossRef] [PubMed]
  16. Dvorak, C.M.T.; Puvanendiran, S.; Murtaugh, M.P. Porcine circovirus 2 infection induces IFNbeta expression through increased expression of genes involved in RIG-I and IRF7 signaling pathways. Virus Res. 2018, 253, 38–47. [Google Scholar] [CrossRef] [PubMed]
  17. Romero, N.; Van Waesberghe, C.; Favoreel, H.W. Pseudorabies Virus Infection of Epithelial Cells Leads to Persistent but Aberrant Activation of the NF-kappaB Pathway, Inhibiting Hallmark NF-kappaB-Induced Proinflammatory Gene Expression. J. Virol. 2020, 94, e00196-20. [Google Scholar] [CrossRef]
  18. Romero, N.; Favoreel, H.W. Pseudorabies Virus Infection Triggers NF-kappaB Activation via the DNA Damage Response but Actively Inhibits NF-kappaB-Dependent Gene Expression. J. Virol. 2021, 95, e0166621. [Google Scholar] [CrossRef]
  19. Sun, W.; Liu, S.; Huang, X.; Yuan, R.; Yu, J. Cytokine storms and pyroptosis are primarily responsible for the rapid death of mice infected with pseudorabies virus. R. Soc. Open Sci. 2021, 8, 210296. [Google Scholar] [CrossRef]
  20. Laval, K.; Vernejoul, J.B.; Van Cleemput, J.; Koyuncu, O.O.; Enquist, L.W. Virulent Pseudorabies Virus Infection Induces a Specific and Lethal Systemic Inflammatory Response in Mice. J. Virol. 2018, 92, e01614-18. [Google Scholar] [CrossRef] [Green Version]
  21. Kekarainen, T.; Montoya, M.; Dominguez, J.; Mateu, E.; Segales, J. Porcine circovirus type 2 (PCV2) viral components immunomodulate recall antigen responses. Vet. Immunol. Immunopathol. 2008, 124, 41–49. [Google Scholar] [CrossRef] [PubMed]
  22. Kekarainen, T.; Montoya, M.; Mateu, E.; Segales, J. Porcine circovirus type 2-induced interleukin-10 modulates recall antigen responses. J. Gen. Virol. 2008, 89 Pt 3, 760–765. [Google Scholar] [CrossRef]
  23. Gao, F.; Xie, J.L.; Jia, C.W.; Ren, H.Y.; Zhou, S.H. Effects of porcine circovirus type 2 and pseudorabies vaccine co-inoculation on regulatory cytokine mRNA expression in pig peripheral blood mononuclear cells. Genet. Mol. Res. 2014, 13, 1540–1547. [Google Scholar] [CrossRef] [PubMed]
  24. Faurez, F.; Grasland, B.; Beven, V.; Cariolet, R.; Keranflec’h, A.; Henry, A.; Jestin, A.; Dory, D. The protective immune response against Pseudorabies virus induced by DNA vaccination is impaired if the plasmid harbors a functional Porcine circovirus type 2 rep and origin of replication. Antiviral Res. 2012, 96, 271–279. [Google Scholar] [CrossRef]
  25. Honda, K.; Takaoka, A.; Taniguchi, T. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 2006, 25, 349–360. [Google Scholar] [CrossRef] [Green Version]
  26. Honda, K.; Yanai, H.; Negishi, H.; Asagiri, M.; Sato, M.; Mizutani, T.; Shimada, N.; Ohba, Y.; Takaoka, A.; Yoshida, N.; et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005, 434, 772–777. [Google Scholar] [CrossRef]
  27. Imada, K.; Leonard, W.J. The Jak-STAT pathway. Mol. Immunol. 2000, 37, 1–11. [Google Scholar] [CrossRef]
  28. Barnabei, L.; Laplantine, E.; Mbongo, W.; Rieux-Laucat, F.; Weil, R. NF-kappaB: At the Borders of Autoimmunity and Inflammation. Front. Immunol. 2021, 12, 716469. [Google Scholar] [CrossRef]
  29. Rathinam, V.A.; Jiang, Z.; Waggoner, S.N.; Sharma, S.; Cole, L.E.; Waggoner, L.; Vanaja, S.K.; Monks, B.G.; Ganesan, S.; Latz, E.; et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat. Immunol. 2010, 11, 395–402. [Google Scholar] [CrossRef] [Green Version]
  30. Zhao, C.; Zhao, W. NLRP3 Inflammasome-A Key Player in Antiviral Responses. Front. Immunol. 2020, 11, 211. [Google Scholar] [CrossRef] [Green Version]
  31. Fusco, R.; Siracusa, R.; Genovese, T.; Cuzzocrea, S.; Di Paola, R. Focus on the Role of NLRP3 Inflammasome in Diseases. Int. J. Mol. Sci. 2020, 21, 4223. [Google Scholar] [CrossRef] [PubMed]
  32. Manley, G.C.A.; Parker, L.C.; Zhang, Y. Emerging Regulatory Roles of Dual-Specificity Phosphatases in Inflammatory Airway Disease. Int. J. Mol. Sci. 2019, 20, 678. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Chen, F.; Yang, X.; Pang, D.; Peng, Z.; Ma, T.; Ouyang, H.; Ren, L. A dark-to-bright reporter cell for classical swine fever virus infection. Antiviral Res. 2015, 117, 44–51. [Google Scholar] [CrossRef] [PubMed]
  34. Yang, X.; Chen, F.; Cao, Y.; Pang, D.; Ouyang, H.; Ren, L. Complete genome sequence of porcine circovirus 2b strain CC1. J. Virol. 2012, 86, 9536. [Google Scholar] [CrossRef] [Green Version]
  35. Shen, H.G.; Zhou, J.Y.; Huang, Z.Y.; Guo, J.Q.; Xing, G.; He, J.L.; Yan, Y.; Gong, L.Y. Protective immunity against porcine circovirus 2 by vaccination with ORF2-based DNA and subunit vaccines in mice. J. Gen. Virol. 2008, 89 Pt 8, 1857–1865. [Google Scholar] [CrossRef]
  36. Peng, Z.; Ouyang, T.; Pang, D.; Ma, T.; Chen, X.; Guo, N.; Chen, F.; Yuan, L.; Ouyang, H.; Ren, L. Pseudorabies virus can escape from CRISPR-Cas9-mediated inhibition. Virus Res. 2016, 223, 197–205. [Google Scholar] [CrossRef]
  37. Ouyang, T.; Niu, G.; Zhang, Y.; Liu, X.; Zhang, X.; Zhang, S.; Geng, Y.; Pang, D.; Ouyang, H.; Ren, L. Porcine HMGCR Inhibits Porcine Circovirus Type 2 Infection by Directly Interacting with the Viral Proteins. Viruses 2019, 11, 544. [Google Scholar] [CrossRef] [Green Version]
  38. Shahriar, S.; Araf, Y.; Ahmad, R.; Kattel, P.; Sah, G.S.; Rahaman, T.I.; Sadiea, R.Z.; Sultana, S.; Islam, M.S.; Zheng, C.; et al. Insights Into the Coinfections of Human Immunodeficiency Virus-Hepatitis B Virus, Human Immunodeficiency Virus-Hepatitis C Virus, and Hepatitis B Virus-Hepatitis C Virus: Prevalence, Risk Factors, Pathogenesis, Diagnosis, and Treatment. Front. Microbiol. 2021, 12, 780887. [Google Scholar] [CrossRef]
  39. Alhumaid, S.; Al Mutair, A.; Al Alawi, Z.; Alshawi, A.M.; Alomran, S.A.; Almuhanna, M.S.; Almuslim, A.A.; Bu Shafia, A.H.; Alotaibi, A.M.; Ahmed, G.Y.; et al. Coinfections with Bacteria, Fungi, and Respiratory Viruses in Patients with SARS-CoV-2: A Systematic Review and Meta-Analysis. Pathogens 2021, 10, 809. [Google Scholar] [CrossRef]
  40. Kim, E.H.; Nguyen, T.Q.; Casel, M.A.B.; Rollon, R.; Kim, S.M.; Kim, Y.I.; Yu, K.M.; Jang, S.G.; Yang, J.; Poo, H.; et al. Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4(+) T Cell Responses. J. Virol. 2022, 96, e0187321. [Google Scholar] [CrossRef]
  41. Wang, Z.; Chen, J.; Zhang, Q.G.; Huang, K.; Ma, D.; Du, Q.; Tong, D.; Huang, Y. Porcine circovirus type 2 infection inhibits the activation of type I interferon signaling via capsid protein and host gC1qR. Vet. Microbiol. 2022, 266, 109354. [Google Scholar] [CrossRef] [PubMed]
  42. Li, J.; Lu, M.; Huang, B.; Lv, Y. Porcine circovirus type 2 inhibits inter-beta expression by targeting Karyopherin alpha-3 in PK-15 cells. Virology 2018, 520, 75–82. [Google Scholar] [CrossRef] [PubMed]
  43. Liu, Q.; Rao, Y.; Tian, M.; Zhang, S.; Feng, P. Modulation of Innate Immune Signaling Pathways by Herpesviruses. Viruses 2019, 11, 572. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Nan, Y.; Wu, C.; Zhang, Y.J. Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism. Front. Immunol. 2017, 8, 1758. [Google Scholar] [CrossRef]
  45. Mallampalli, R.K.; Adair, J.; Elhance, A.; Farkas, D.; Chafin, L.; Long, M.E.; De, M.; Mora, A.L.; Rojas, M.; Peters, V.; et al. Interferon Lambda Signaling in Macrophages Is Necessary for the Antiviral Response to Influenza. Front. Immunol. 2021, 12, 735576. [Google Scholar] [CrossRef]
  46. Nelli, R.K.; Mora-Diaz, J.C.; Gimenez-Lirola, L.G. The Betacoronavirus PHEV Replicates and Disrupts the Respiratory Epithelia and Upregulates Key Pattern Recognition Receptor Genes and Downstream Mediators, Including IL-8 and IFN-lambda. mSphere 2021, 6, e0082021. [Google Scholar] [CrossRef]
  47. Yin, Y.; Favoreel, H.W. Herpesviruses and the Type III Interferon System. Virol. Sin. 2021, 36, 577–587. [Google Scholar] [CrossRef]
  48. Pervolaraki, K.; Stanifer, M.L.; Munchau, S.; Renn, L.A.; Albrecht, D.; Kurzhals, S.; Senis, E.; Grimm, D.; Schroder-Braunstein, J.; Rabin, R.L.; et al. Type I and Type III Interferons Display Different Dependency on Mitogen-Activated Protein Kinases to Mount an Antiviral State in the Human Gut. Front. Immunol. 2017, 8, 459. [Google Scholar] [CrossRef]
  49. Wei, L.; Kwang, J.; Wang, J.; Shi, L.; Yang, B.; Li, Y.; Liu, J. Porcine circovirus type 2 induces the activation of nuclear factor kappa B by IkappaBalpha degradation. Virology 2008, 378, 177–184. [Google Scholar] [CrossRef] [Green Version]
  50. Jang, D.I.; Lee, A.H.; Shin, H.Y.; Song, H.R.; Park, J.H.; Kang, T.B.; Lee, S.R.; Yang, S.H. The Role of Tumor Necrosis Factor Alpha (TNF-alpha) in Autoimmune Disease and Current TNF-alpha Inhibitors in Therapeutics. Int. J. Mol. Sci. 2021, 22, 2719. [Google Scholar] [CrossRef]
  51. Aggarwal, B.B. Signalling pathways of the TNF superfamily: A double-edged sword. Nat. Rev. Immunol. 2003, 3, 745–756. [Google Scholar] [CrossRef] [PubMed]
Ijms 23 04469 g001 550
Figure 1. Coinfection of PCV2 and PRV affects in PK-15 cells. Viral genomic copies were evaluated using real-time PCR at indicated hour post-infection. The data are presented as the means ± SD. **, p-value < 0.01; ***, p-value < 0.001; ****, p-value < 0.0001. (A) PCV2. (B) PRV.
Figure 1. Coinfection of PCV2 and PRV affects in PK-15 cells. Viral genomic copies were evaluated using real-time PCR at indicated hour post-infection. The data are presented as the means ± SD. **, p-value < 0.01; ***, p-value < 0.001; ****, p-value < 0.0001. (A) PCV2. (B) PRV.
Ijms 23 04469 g001
Ijms 23 04469 g002 550
Figure 2. Coinfection of PCV2 and PRV modulates IFNs. Western blotting was performed using Interferon alpha 1 Antibody, Interferon beta/IFNB, IFN-γ, IL28/29 (H-1), and Anti-β-Actin Antibody as primary antibodies, respectively. HRP-labeled Goat Anti-mouse IgG (H+L) and HRP-labeled Goat Anti-rabbit IgG (H+L) were used as the secondary antibody. β-actin was used as a control. The average expression level of the target protein in each group is shown below each lane. The protein amount of the PK-15 group is set to 1, and the values of other groups are the ratio with the PK-15 group. Unprocessed original images can be found in Supplementary Figure S1.
Figure 2. Coinfection of PCV2 and PRV modulates IFNs. Western blotting was performed using Interferon alpha 1 Antibody, Interferon beta/IFNB, IFN-γ, IL28/29 (H-1), and Anti-β-Actin Antibody as primary antibodies, respectively. HRP-labeled Goat Anti-mouse IgG (H+L) and HRP-labeled Goat Anti-rabbit IgG (H+L) were used as the secondary antibody. β-actin was used as a control. The average expression level of the target protein in each group is shown below each lane. The protein amount of the PK-15 group is set to 1, and the values of other groups are the ratio with the PK-15 group. Unprocessed original images can be found in Supplementary Figure S1.
Ijms 23 04469 g002
Ijms 23 04469 g003 550
Figure 3. Coinfection of PCV2 and PRV regulates IRFs. (A,B) Expression levels of IRFs. The mRNA levels of IRF3 (A) and IRF7 (B) were evaluated via real-time PCR. (C) Protein levels of IRF7. Western blotting was performed using Rabbit Anti-IRF7 antibody and Anti-β-Actin Antibody as primary antibodies, respectively. HRP-labeled Goat Anti-mouse IgG (H+L) and HRP-labeled Goat Anti-rabbit IgG (H+L) were used as the secondary antibody. β-actin was used as a control. The average expression level of the target protein in each group is shown below each lane. The protein amount of the PK-15 group is set to 1, and the values of other groups are the ratio with the PK-15 group. (D,E) Expression levels of ISGs. The mRNA levels of ISG15 (D) and ISG56 (E) were evaluated via real-time PCR. *, p-value < 0.05; **, p-value < 0.01; ***, p-value < 0.001; ****, p-value < 0.0001. The data are presented as the means ± SD. Unprocessed original images can be found in Supplementary Figure S2.
Figure 3. Coinfection of PCV2 and PRV regulates IRFs. (A,B) Expression levels of IRFs. The mRNA levels of IRF3 (A) and IRF7 (B) were evaluated via real-time PCR. (C) Protein levels of IRF7. Western blotting was performed using Rabbit Anti-IRF7 antibody and Anti-β-Actin Antibody as primary antibodies, respectively. HRP-labeled Goat Anti-mouse IgG (H+L) and HRP-labeled Goat Anti-rabbit IgG (H+L) were used as the secondary antibody. β-actin was used as a control. The average expression level of the target protein in each group is shown below each lane. The protein amount of the PK-15 group is set to 1, and the values of other groups are the ratio with the PK-15 group. (D,E) Expression levels of ISGs. The mRNA levels of ISG15 (D) and ISG56 (E) were evaluated via real-time PCR. *, p-value < 0.05; **, p-value < 0.01; ***, p-value < 0.001; ****, p-value < 0.0001. The data are presented as the means ± SD. Unprocessed original images can be found in Supplementary Figure S2.
Ijms 23 04469 g003
Ijms 23 04469 g004 550
Figure 4. Coinfection of PCV2 and PRV suppresses STAT1-related JAK/STAT pathways. (A–D) Expression levels of JAK/STATs. The relative mRNA levels of JAK1 (A), SOCS1 (B), SOCS3 (C), and STAT1 (D) were detected using real-time PCR. (E,F) Protein levels of STAT1 and IRF9. Western blotting was performed using p-STAT1, Anti-STAT1 Antibody, IRF9 Antibody, and Anti-β-Actin Antibody as primary antibodies, respectively. HRP-labeled Goat Anti-mouse IgG (H+L) and HRP-labeled Goat Anti-rabbit IgG (H+L) were used as the secondary antibody. β-actin was used as a control. The average expression level of the target protein in each group is shown below each lane. The protein amount of the PK-15 group is set to 1, and the values of other groups are the ratio with the PK-15 group. (G) Expression levels of IRF9 were detected using real-time PCR. The data are presented as the means ± SD. *, p-value < 0.05; **, p-value < 0.01; ***, p-value < 0.001; ****, p-value < 0.0001. Unprocessed original images can be found in Supplementary Figure S3.
Figure 4. Coinfection of PCV2 and PRV suppresses STAT1-related JAK/STAT pathways. (A–D) Expression levels of JAK/STATs. The relative mRNA levels of JAK1 (A), SOCS1 (B), SOCS3 (C), and STAT1 (D) were detected using real-time PCR. (E,F) Protein levels of STAT1 and IRF9. Western blotting was performed using p-STAT1, Anti-STAT1 Antibody, IRF9 Antibody, and Anti-β-Actin Antibody as primary antibodies, respectively. HRP-labeled Goat Anti-mouse IgG (H+L) and HRP-labeled Goat Anti-rabbit IgG (H+L) were used as the secondary antibody. β-actin was used as a control. The average expression level of the target protein in each group is shown below each lane. The protein amount of the PK-15 group is set to 1, and the values of other groups are the ratio with the PK-15 group. (G) Expression levels of IRF9 were detected using real-time PCR. The data are presented as the means ± SD. *, p-value < 0.05; **, p-value < 0.01; ***, p-value < 0.001; ****, p-value < 0.0001. Unprocessed original images can be found in Supplementary Figure S3.
Ijms 23 04469 g004
Ijms 23 04469 g005 550
Figure 5. Coinfection of PCV2 and PRV modulates the NF-κB signal pathway. (A,B) Expression levels of iκB and p65. The relative mRNA levels of iκB (A) and p65 (B) were examined using real-time PCR. The data are presented as the means ± SD. **, p-value < 0.01; ***, p-value < 0.001; ****, p-value < 0.0001. (C–E) Protein levels of p65 and iκB. Western blotting was conducted using P-IΚBα (Ser32 Ser36), IΚB-α, NFκB p65 Polyclonal Antibody, Phospho-NFκB p65 (Thr276) Polyclonal Antibody, and Anti-β-Actin Antibody as primary antibody, respectively. HRP-labeled Goat Anti-mouse IgG (H+L) and HRP-labeled Goat Anti-rabbit IgG (H+L) were used as the secondary antibody. β-actin was used as a control. The average expression level of the target protein in each group is shown below each lane. The protein amount of the PK-15 group is set to 1, and the values of other groups are the ratio with the PK-15 group. Unprocessed original images can be found in Supplementary Figure S4.
Figure 5. Coinfection of PCV2 and PRV modulates the NF-κB signal pathway. (A,B) Expression levels of iκB and p65. The relative mRNA levels of iκB (A) and p65 (B) were examined using real-time PCR. The data are presented as the means ± SD. **, p-value < 0.01; ***, p-value < 0.001; ****, p-value < 0.0001. (C–E) Protein levels of p65 and iκB. Western blotting was conducted using P-IΚBα (Ser32 Ser36), IΚB-α, NFκB p65 Polyclonal Antibody, Phospho-NFκB p65 (Thr276) Polyclonal Antibody, and Anti-β-Actin Antibody as primary antibody, respectively. HRP-labeled Goat Anti-mouse IgG (H+L) and HRP-labeled Goat Anti-rabbit IgG (H+L) were used as the secondary antibody. β-actin was used as a control. The average expression level of the target protein in each group is shown below each lane. The protein amount of the PK-15 group is set to 1, and the values of other groups are the ratio with the PK-15 group. Unprocessed original images can be found in Supplementary Figure S4.
Ijms 23 04469 g005
Ijms 23 04469 g006 550
Figure 6. Coinfection of PCV2 and PRV modulates expressions of host pro-inflammatory factors. (A–D) Expression levels of pro-inflammatory factors. The relative mRNA levels of IL1α (A), TNFα (B), IL6 (C), and IL1β (D) were evaluated using real-time PCR. The data are presented as the means ± SD. *, p-value < 0.05; **, p-value < 0.01; ***, p-value < 0.001; ****, p-value < 0.0001. (E) Protein levels of pro-inflammatory factors. Western blotting was performed using IL1α, IL1B Antibody, IL6, TNFα, and Anti-β-Actin Antibody as primary antibodies, respectively. HRP-labeled Goat Anti-mouse IgG (H+L) and HRP-labeled Goat Anti-rabbit IgG (H+L) were used as the secondary antibody. β-actin was used as a control. The average expression level of the target protein in each group is shown below each lane. The protein amount of the PK-15 group is set to 1, and the values of other groups are the ratio with the PK-15 group. Unprocessed original images can be found in Supplementary Figure S5.
Figure 6. Coinfection of PCV2 and PRV modulates expressions of host pro-inflammatory factors. (A–D) Expression levels of pro-inflammatory factors. The relative mRNA levels of IL1α (A), TNFα (B), IL6 (C), and IL1β (D) were evaluated using real-time PCR. The data are presented as the means ± SD. *, p-value < 0.05; **, p-value < 0.01; ***, p-value < 0.001; ****, p-value < 0.0001. (E) Protein levels of pro-inflammatory factors. Western blotting was performed using IL1α, IL1B Antibody, IL6, TNFα, and Anti-β-Actin Antibody as primary antibodies, respectively. HRP-labeled Goat Anti-mouse IgG (H+L) and HRP-labeled Goat Anti-rabbit IgG (H+L) were used as the secondary antibody. β-actin was used as a control. The average expression level of the target protein in each group is shown below each lane. The protein amount of the PK-15 group is set to 1, and the values of other groups are the ratio with the PK-15 group. Unprocessed original images can be found in Supplementary Figure S5.
Ijms 23 04469 g006
Ijms 23 04469 g007 550
Figure 7. Coinfection of PCV2 and PRV activates the NLRP3 pathway. (A,B) Expression levels of NLRP3 and COX2. The relative mRNA levels of NLRP3 (A) and COX2 (B) were examined via Real-time PCR. The data are presented as the means ± SD. *, p-value < 0.05; **, p-value < 0.01; ***, p-value < 0.001; ****, p-value < 0.0001. (C) Protein levels of NLRP3 and COX2. Western blotting was performed using NLRP3, Cox-2, and Anti-β-Actin Antibody as primary antibodies, respectively. HRP-labeled Goat Anti-mouse IgG (H+L) and HRP-labeled Goat Anti-rabbit IgG (H+L) were used as the secondary antibody. β-actin was used as a control. The average expression level of the target protein in each group is shown below each lane. The protein amount of the PK-15 group is set to 1, and the values of other groups are the ratio with the PK-15 group. Unprocessed original images can be found in Supplementary Figure S6.
Figure 7. Coinfection of PCV2 and PRV activates the NLRP3 pathway. (A,B) Expression levels of NLRP3 and COX2. The relative mRNA levels of NLRP3 (A) and COX2 (B) were examined via Real-time PCR. The data are presented as the means ± SD. *, p-value < 0.05; **, p-value < 0.01; ***, p-value < 0.001; ****, p-value < 0.0001. (C) Protein levels of NLRP3 and COX2. Western blotting was performed using NLRP3, Cox-2, and Anti-β-Actin Antibody as primary antibodies, respectively. HRP-labeled Goat Anti-mouse IgG (H+L) and HRP-labeled Goat Anti-rabbit IgG (H+L) were used as the secondary antibody. β-actin was used as a control. The average expression level of the target protein in each group is shown below each lane. The protein amount of the PK-15 group is set to 1, and the values of other groups are the ratio with the PK-15 group. Unprocessed original images can be found in Supplementary Figure S6.
Ijms 23 04469 g007
Ijms 23 04469 g008 550
Figure 8. Coinfection of PCV2 and PRV activates inflammatory and immune responses via p38 and JNK1/2. (A–C) Expression levels of MAPKs. The relative mRNA levels of p38 (A), ERK1/2 (B), and JNK1/2 (C) were examined via real-time PCR. The data are presented as the means ± SD. *, p-value < 0.05; **, p-value < 0.01; ***, p-value < 0.001; ****, p-value < 0.0001. (D–G) Protein levels of MAPKs. Western blotting was conducted using p-p38 (Thr180/Tyr182), P38, JNK (FL), p-JNK (Thr 183/Tyr 185), ERK p44/42 MAPK (Erk1/2) (137F5) Rabbit mAb, Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (D13.14.4E) XP® Rabbit mAb, and Anti-β-Actin Antibody as primary antibody, respectively. HRP-labeled Goat Anti-mouse IgG (H+L), HRP-labeled Donkey Anti-Goat IgG (H+L), and HRP-labeled Goat Anti-rabbit IgG (H+L) were used as the secondary antibody. β-actin was used as a control. The average expression level of the target protein in each group is shown below each lane. The protein amount of the PK-15 group is set to 1, and the values of other groups are the ratio with the PK-15 group. Unprocessed original images can be found in Supplementary Figure S7.
Figure 8. Coinfection of PCV2 and PRV activates inflammatory and immune responses via p38 and JNK1/2. (A–C) Expression levels of MAPKs. The relative mRNA levels of p38 (A), ERK1/2 (B), and JNK1/2 (C) were examined via real-time PCR. The data are presented as the means ± SD. *, p-value < 0.05; **, p-value < 0.01; ***, p-value < 0.001; ****, p-value < 0.0001. (D–G) Protein levels of MAPKs. Western blotting was conducted using p-p38 (Thr180/Tyr182), P38, JNK (FL), p-JNK (Thr 183/Tyr 185), ERK p44/42 MAPK (Erk1/2) (137F5) Rabbit mAb, Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (D13.14.4E) XP® Rabbit mAb, and Anti-β-Actin Antibody as primary antibody, respectively. HRP-labeled Goat Anti-mouse IgG (H+L), HRP-labeled Donkey Anti-Goat IgG (H+L), and HRP-labeled Goat Anti-rabbit IgG (H+L) were used as the secondary antibody. β-actin was used as a control. The average expression level of the target protein in each group is shown below each lane. The protein amount of the PK-15 group is set to 1, and the values of other groups are the ratio with the PK-15 group. Unprocessed original images can be found in Supplementary Figure S7.
Ijms 23 04469 g008
Ijms 23 04469 g009 550
Figure 9. Proposed immune and inflammatory reactions caused by coinfection of PCV2 and PRV. Arrow (→), enhance; T line (⊥) means inhibition.
Figure 9. Proposed immune and inflammatory reactions caused by coinfection of PCV2 and PRV. Arrow (→), enhance; T line (⊥) means inhibition.
Ijms 23 04469 g009
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Li, X.; Chen, S.; Zhang, L.; Niu, G.; Zhang, X.; Yang, L.; Ji, W.; Ren, L. Coinfection of Porcine Circovirus 2 and Pseudorabies Virus Enhances Immunosuppression and Inflammation through NF-κB, JAK/STAT, MAPK, and NLRP3 Pathways. Int. J. Mol. Sci. 2022, 23, 4469. https://doi.org/10.3390/ijms23084469

AMA Style

Li X, Chen S, Zhang L, Niu G, Zhang X, Yang L, Ji W, Ren L. Coinfection of Porcine Circovirus 2 and Pseudorabies Virus Enhances Immunosuppression and Inflammation through NF-κB, JAK/STAT, MAPK, and NLRP3 Pathways. International Journal of Molecular Sciences. 2022; 23(8):4469. https://doi.org/10.3390/ijms23084469

Chicago/Turabian Style

Li, Xue, Si Chen, Liying Zhang, Guyu Niu, Xinwei Zhang, Lin Yang, Weilong Ji, and Linzhu Ren. 2022. "Coinfection of Porcine Circovirus 2 and Pseudorabies Virus Enhances Immunosuppression and Inflammation through NF-κB, JAK/STAT, MAPK, and NLRP3 Pathways" International Journal of Molecular Sciences 23, no. 8: 4469. https://doi.org/10.3390/ijms23084469

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop